Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1977 Jan;27(1):92–99.

Lymphocyte reactivity to mitogens in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma.

D A Horwitz, M A Garrett
PMCID: PMC1540894  PMID: 300308

Abstract

The mitogenic reactivity of lymphocytes from subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma was studied. Cultures containing either unseparated or separated lymphocytes were stimulated with phytohaemagglutinin, Con A and pokeweed mitogen after inhibitory serum factors were eluted from the cell surface. Incorporation of [3H]thymidine in patient cultures was compared to that of normal controls. Greatly decreased reactivity was found in SLE to all three mitogens. Significantly decreased values to some mitogens was also observed in rheumatoid arthritis and scleroderma, but the defect was less severe. Cultures of study subjects contained significantly fewer small lymphocytes than normal controls and this finding explained at least in part the decreased mitogenic reactivity.

Full text

PDF
94

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALLISON A. C., YOUNG M. R. UPTAKE OF DYES AND DRUGS BY LIVING CELLS IN CULTURE. Life Sci. 1964 Dec;3:1407–1414. doi: 10.1016/0024-3205(64)90082-7. [DOI] [PubMed] [Google Scholar]
  2. Astorga G. P., Williams R. C., Jr Altered reactivity in mixed lymphocyte culture of lymphocytes from patients with rheumatoid arthritis. Arthritis Rheum. 1969 Dec;12(6):547–554. doi: 10.1002/art.1780120602. [DOI] [PubMed] [Google Scholar]
  3. Block S. R., Gibbs C. B., Stevens M. B., Shulman L. E. Delayed hypersensitivity in systemic lupus erythematosus. Ann Rheum Dis. 1968 Jul;27(4):311–318. doi: 10.1136/ard.27.4.311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brooks W. H., Netsky M. G., Normansell D. E., Horwitz D. A. Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor. J Exp Med. 1972 Dec 1;136(6):1631–1647. doi: 10.1084/jem.136.6.1631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cooperband S. R., Davis R. C., Schmid K., Mannick J. A. Competitive blockade of lymphocyte stimulation by a serum immuno-regulatory alpha globulin (IRA). Transplant Proc. 1969 Mar;1(1):516–523. [PubMed] [Google Scholar]
  6. Crout J. E., Hepburn B., Ritts R. E., Jr Suppression of lymphocyte transformation after aspirin ingestion. N Engl J Med. 1975 Jan 30;292(5):221–223. doi: 10.1056/NEJM197501302920501. [DOI] [PubMed] [Google Scholar]
  7. Delbarre F., Pompidou A., Kahan A., Brouilhet H., Le Gô A., Amor B. Etude des lymphocytes du sang au cours de la maladie lupique. Pathol Biol (Paris) 1971 Apr;19(7):379–387. [PubMed] [Google Scholar]
  8. Dormont J., Sobel A., Galanaud P., Boelaert J., Mery J. P., Richet G. Exploration de l'immunité cellulaire au cours du lupus érythémateux disséminé. J Urol Nephrol (Paris) 1972 Dec;78(12):980–987. [PubMed] [Google Scholar]
  9. Goldman J. A., Litwin A., Adams L. E., Krueger R. C., Hess E. V. Cellular immunity to nuclear antigens in systemic lupus erythematosus. J Clin Invest. 1972 Oct;51(10):2669–2677. doi: 10.1172/JCI107085. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hersh E. M., Harris J. E., Rogers E. A. Influence of cell density on response of leukocytes and column-purified lymphocytes to mitogenic agents. J Reticuloendothel Soc. 1970 May;7(5):567–586. [PubMed] [Google Scholar]
  11. Horwitz D. A., Cousar J. B. A relationship between impaired cellular immunity humoral suppression of lymphocyte function and severity of systemic lupus erythematosus. Am J Med. 1975 Jun;58(6):829–835. doi: 10.1016/0002-9343(75)90639-7. [DOI] [PubMed] [Google Scholar]
  12. Horwitz D. A., Garrett M. A., Craig A. H. Serum effects of mitogenic reactivity in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma. Technical considerations and lack of correlation with anti-lymphocyte antibodies. Clin Exp Immunol. 1977 Jan;27(1):100–110. [PMC free article] [PubMed] [Google Scholar]
  13. Horwitz D. A. Impaired delayed hypersensitivity in systemic lupus erythematosus. Arthritis Rheum. 1972 Jul-Aug;15(4):353–359. doi: 10.1002/art.1780150406. [DOI] [PubMed] [Google Scholar]
  14. Horwitz D. A., Lobo P. I. Characterizaiton of two populations of human lymphocytes bearing easily detectable surface immunoglobulin. J Clin Invest. 1975 Dec;56(6):1464–1472. doi: 10.1172/JCI108227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Horwitz D. A. The development of macrophages from large mononuclear cells in the blood of patients with inflammatory disease. J Clin Invest. 1972 Apr;51(4):760–768. doi: 10.1172/JCI106870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Janossy G., Greaves M. F. Lymphocyte activation. I. Response of T and B lymphocytes to phytomitogens. Clin Exp Immunol. 1971 Oct;9(4):483–498. [PMC free article] [PubMed] [Google Scholar]
  17. Kacaki J. N., Bullock W. E., Vaughan J. H. Failure of lymphocyte transformation in response to gamma-globulins in rheumatoid arthritis. Lancet. 1969 Jun 28;1(7609):1289–1290. doi: 10.1016/s0140-6736(69)92224-7. [DOI] [PubMed] [Google Scholar]
  18. Kirchner H., Chused T. M., Herberman R. B., Holden H. T., Lavrin D. H. Evidence of suppressor cell activity in spleens of mice bearing primary tumors induced by Moloney sarcoma virus. J Exp Med. 1974 Jun 1;139(6):1473–1487. doi: 10.1084/jem.139.6.1473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lance E. M., Knight S. C. Immunologic reactivity in rheumatoid arthritis. Response to mitogens. Arthritis Rheum. 1974 Sep-Oct;17(5):513–520. doi: 10.1002/art.1780170504. [DOI] [PubMed] [Google Scholar]
  20. Lockshin M. D., Eisenhauer A. C., Kohn R., Weksler M., Block S., Mushlin S. B. Cell-mediated immunity in rheumatic diseases. II. Mitogen responses in RA, SLE, and other illnesses: correlation with T- and B-lymphocyte populations. Arthritis Rheum. 1975 May-Jun;18(3):245–250. doi: 10.1002/art.1780180308. [DOI] [PubMed] [Google Scholar]
  21. Malavé I., Layrisse Z., Layrisse M. Dose-dependent hyporreactivity to phytohemagglutinin in systemic lupus erythematosus. Cell Immunol. 1975 Feb;15(2):231–236. doi: 10.1016/0008-8749(75)90001-5. [DOI] [PubMed] [Google Scholar]
  22. Mellbye O. J., Messner R. P., DeBord J. R., Williams R. C., Jr Immunoglobulin and receptors for C3 on lymphocytes from patients with rheumatoid arthritis. Arthritis Rheum. 1972 Jul-Aug;15(4):371–380. doi: 10.1002/art.1780150408. [DOI] [PubMed] [Google Scholar]
  23. Moorhead J. F., Connolly J. J., McFarland W. Factors affecting the reactivity of human lymphocytes in vitro. I. Cell number, duration of culture and surface area. J Immunol. 1967 Aug;99(2):413–419. [PubMed] [Google Scholar]
  24. Nelson S. D., Mackay J. S., Sheridan B., Weaver J. A. Intermittent corticotrophin therapy. Study of lymphocyte transformation in vitro in rheumatoid arthritis. Ann Rheum Dis. 1969 Sep;28(5):524–528. doi: 10.1136/ard.28.5.524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Opelz G., Terasaki P. I., Hirata A. A. Suppression of lymphocyte transformation by aspirin. Lancet. 1973 Sep 1;2(7827):478–480. doi: 10.1016/s0140-6736(73)92073-4. [DOI] [PubMed] [Google Scholar]
  26. Pachman L. M., Esterly N. B., Peterson R. D. The effect of salicylate on the metabolism of normal and stimulated human lymphocytes in vitro. J Clin Invest. 1971 Jan;50(1):226–230. doi: 10.1172/JCI106478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Parker C. W., Vavra J. D. Immunosuppression. Prog Hematol. 1969;6:1–81. [PubMed] [Google Scholar]
  28. Paty J. G., Sienknecht C. W., Townes A. S., Hanissian A. S., Masi A. T. Proceedings: Impaired cell-mediated immunity in systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Arthritis Rheum. 1974 May-Jun;17(3):324–324. [PubMed] [Google Scholar]
  29. Reynolds M. D., Abdou N. I. Comparative study of the in vitro proliferative responses of blood and synovial fluid leukocytes of rheumatoid arthritis patients. J Clin Invest. 1973 Jul;52(7):1627–1631. doi: 10.1172/JCI107341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Senyk G., Hadley W. K., Attias M. R., Talal N. Cellular immunity in systemic lupus erythematosus. Arthritis Rheum. 1974 Sep-Oct;17(5):553–562. doi: 10.1002/art.1780170509. [DOI] [PubMed] [Google Scholar]
  31. Smith M. J., Hoth M., Davis K. Aspirin and lymphocyte transformation. Ann Intern Med. 1975 Oct;83(4):509–511. doi: 10.7326/0003-4819-83-4-509. [DOI] [PubMed] [Google Scholar]
  32. Suciu-Foca N., Buda J. A., Thiem T., Reemtsma K. Impaired responsiveness of lymphocytes in patients with systemic lupus erythematosus. Clin Exp Immunol. 1974 Nov;18(3):295–301. [PMC free article] [PubMed] [Google Scholar]
  33. Thurman G. B., Strong D. M., Ahmed A., Green S. S., Sell K. W., Hartzman R. J., Bach F. H. Human mixed lymphocyte cultures. Evaluation of a microculture technique utilizing the Multiple Automated Sample Harvester (MASH). Clin Exp Immunol. 1973 Oct;15(2):289–302. [PMC free article] [PubMed] [Google Scholar]
  34. Toh B. H., Roberts-Thomson I. C., Mathews J. D., Whittingham S., Mackay I. R. Depression of cell-mediated immunity in old age and the immunopathic diseases, lupus erythematosus, chronic hepatitis and rheumatoid arthritis. Clin Exp Immunol. 1973 Jun;14(2):193–202. [PMC free article] [PubMed] [Google Scholar]
  35. Waxman J., Lockshin M. D., Schnapp J. J., Doneson I. N. Cellular immunity in rheumatic diseases. I. Rheumatoid arthritis. Arthritis Rheum. 1973 Jul-Aug;16(4):499–506. doi: 10.1002/art.1780160410. [DOI] [PubMed] [Google Scholar]
  36. Yamamura M. Standardization of lymphocyte transformation to phytohaemagglutinin. Clin Exp Immunol. 1973 Jul;14(3):457–467. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES